期刊
MEDICINA CLINICA
卷 138, 期 11, 页码 483-488出版社
ELSEVIER DOYMA SL
DOI: 10.1016/j.medcli.2011.04.024
关键词
Hepatitis B; Antiviral therapy; HBsAg
The surface antigen of hepatitis B virus (HBsAg) is the main serological marker of HBV infection since its discovery almost 50 years ago. Currently the quantification of HBsAg has acquired special relevance as there are commercial tests to measure its levels. Several studies have shown that in patients treated with pegylated interferon alfa the fall of HBsAg levels predicts the loss of HBsAg and persistent virologic response. The role of the quantification of HBsAg in the treatment with nucleoside analogues is still not well understood and requires further studies. (C) 2011 Elsevier Espana, S.L. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据